Cargando…

Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT

Rituximab (RTX) is an anti-CD20 monoclonal antibody that targets B cells—from the immature pre-B-cell stage in the bone marrow to mature circulating B cells—while preserving stem cells and plasma cells. It is used to treat autoimmune diseases, hematological malignancies, or complications after hemat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luterbacher, Fanny, Bernard, Fanette, Baleydier, Frédéric, Ranza, Emmanuelle, Jandus, Peter, Blanchard-Rohner, Geraldine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727997/ https://www.ncbi.nlm.nih.gov/pubmed/35003091 http://dx.doi.org/10.3389/fimmu.2021.773853

Ejemplares similares

Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect
por: Ott de Bruin, Lisa M., et al.
Publicado: (2023)

Rituximab Use and Hypogammaglobulinemia
por: Alhassan, Eaman, et al.
Publicado: (2020)

Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia
por: Ohmoto, Akihiro, et al.
Publicado: (2022)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
por: Tieu, Joanna, et al.
Publicado: (2021)

PD42 - Is rituximab a trigger for persistent hypogammaglobulinemia in idiopathic nephrotic syndrome?
por: Trujillo, Juan Enrique, et al.
Publicado: (2014)

The Possibilities of Immunotherapy for Children with Primary Immunodeficiencies Associated with Cancers
por: Baleydier, Frederic, et al.
Publicado: (2020)

Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
por: Khojah, Amer M., et al.
Publicado: (2019)

Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab
por: Perriguey, Marine, et al.
Publicado: (2021)

Case report: Persistent hypogammaglobulinemia in thymoma-associated myasthenia gravis: the impact of rituximab or Good's syndrome?
por: Ren, Jingru, et al.
Publicado: (2023)

Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia
por: Barmettler, Sara, et al.
Publicado: (2018)

Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders
por: Marcinnò, Andrea, et al.
Publicado: (2018)

Is Rituximab-Associated Hypogammaglobulinemia Always Linked to B-Cell Depletion?
por: Damianaki, Anthie, et al.
Publicado: (2022)

Secondary Hypogammaglobulinemia After Rituximab for Neuromyelitis Optica: A Case Report
por: Farhat, Lara, et al.
Publicado: (2018)

Hypogammaglobulinemia following COVID-19 infection in a patient on maintenance rituximab
por: O’Bryan, Collin, et al.
Publicado: (2021)

Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course
por: Tariq, Anam, et al.
Publicado: (2022)

Fatal Hypogammaglobulinemia 3 Years after Rituximab in a Patient with Immune Thrombocytopenia: An Underlying Genetic Predisposition?
por: Viallard, Jean-François, et al.
Publicado: (2019)

Hypogammaglobulinemia Observed One Year after Rituximab Treatment for Idiopathic Thrombocytopenic Purpura
por: Shoukat, Bilal Ahmad, et al.
Publicado: (2018)

Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody–Associated Diseases
por: Avouac, Alexandre, et al.
Publicado: (2021)

Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
por: Zurowska, Aleksandra, et al.
Publicado: (2023)

Childhood-Onset Movement Disorders Can Mask a Primary Immunodeficiency: 6 Cases of Classical Ataxia-Telangiectasia and Variant Forms
por: Blanchard-Rohner, Geraldine, et al.
Publicado: (2022)

Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab
por: Besada, Emilio
Publicado: (2016)

Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study
por: Wade, Stefanie D., et al.
Publicado: (2021)

Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia
por: Kainulainen, Leena, et al.
Publicado: (2010)

Risk Factors and Adverse Events Poorly Predict Infections and Hypogammaglobulinemia in Granulomatosis with Polyangiitis Patients Receiving Rituximab
por: Besada, Emilio
Publicado: (2016)

Hypogammaglobulinemia with Facial Edema
por: Knight, Adina Kay, et al.
Publicado: (2006)

Rituximab-induced IgG hypogammaglobulinemia in children with nephrotic syndrome and normal pre-treatment IgG values
por: Marzuillo, Pierluigi, et al.
Publicado: (2019)

Tonsillar granuloma associated with hypogammaglobulinemia
por: Laajala, Aleksi, et al.
Publicado: (2020)

Lymphocytosis, Lymphocytopenia, Hypergammaglobulinemia, and Hypogammaglobulinemia
por: Mims, Martha P.
Publicado: (2018)

COVID-19, plasma, and hypogammaglobulinemia
por: Murphy, Michael F., et al.
Publicado: (2020)

Rituximab-Induced Hypogammaglobulinemia and Risk of Infection in Neuromyelitis Optica Spectrum Disorders: A 14-Year Real-Life Experience
por: Kim, Su-Hyun, et al.
Publicado: (2022)

Infection Risk, Mortality, and Hypogammaglobulinemia Prevalence and Associated Factors in Adults Treated with Rituximab: A Tertiary Care Center Experience
por: Alhamadh, Moustafa S., et al.
Publicado: (2023)

Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT
por: Burns, D M, et al.
Publicado: (2016)

Immunoglobulin Replacement Therapy in Secondary Hypogammaglobulinemia
por: Compagno, Nicolò, et al.
Publicado: (2014)

Hypogammaglobulinemia due to CAR T-cell therapy
por: Doan, Andrew, et al.
Publicado: (2017)

Hypogammaglobulinemia: a diagnosis that must not be overlooked
por: Pimenta, F.M.C.A., et al.
Publicado: (2019)

Hypogammaglobulinemia in pediatric kidney transplant recipients
por: Dimitriades, Victoria, et al.
Publicado: (2022)

Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases
por: Peterlin, Pierre, et al.
Publicado: (2018)

Native joint polyarticular septic arthritis secondary to disseminated Ureaplasma urealyticum infection in a patient on rituximab therapy with hypogammaglobulinemia: A Case Report
por: El Zein, Said, et al.
Publicado: (2023)

606 Case Report: Hypogammaglobulinemia Induced by Oxcarbazepine
por: Marinovic, Maria Angelica, et al.
Publicado: (2012)

B cell aplasia and hypogammaglobulinemia associated with levetiracetam
por: Ozdemir, Hulya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gcc1aq1rdomf4ggrct9thpmo63